|
|
|
|
|
|
|
IRadimed Corporation (IRMD)
|
|
22.3 -0.35 (-1.55%)
|
07-16 16:00
|
|
Open:
|
22.65
|
Pre. Close:
|
22.65
|
|
High:
|
22.65
|
Low:
|
21.6116
|
|
Volume:
|
31,143
|
Market Cap:
|
238M
|
|
|
|
Stock Price Prediction (Update at 5:00pm est.)
|
|
If
tomorrow:
|
Open
lower
|
Open
higher
|
|
High:
|
22.698 - 22.835
|
22.835 - 22.936
|
|
Low:
|
21.292 - 21.469
|
21.469 - 21.6
|
|
Close:
|
22.063 - 22.329
|
22.329 - 22.527
|
|
|
|
Technical analysis (as of: 2018-07-16 4:40:53 PM)
|
|
Overall:
|
 
|
|
Stoxline posted a SELL today, downgraded from higher rating. This stock seems to be ready for a new bearish move. So you may continue to hold short positions or sell your long positions. You are relatively safe to short or sell now, downward move is expected.
|
|
Target:
|
Six months: 27.54 One year: 32.16
|
|
Support:
|
Support1: 20.35 Support2: 18.35
|
|
Resistance:
|
Resistance1:
23.58 Resistance2: 27.54
|
|
Pivot:
|
21.27 
|
|
Moving Averages:
|
MA(5): 22.70 MA(20): 20.72
MA(100): 17.05 MA(250): 14.09
|
|
MACD:
|
MACD(12,26):
1.04 Signal(12,26,9): 0.87
|
|
%K %D:
|
%K(14,3): 79.27 %D(3): 83.97
|
|
RSI:
|
RSI(14): 72.16
|
|
52-Week:
|
High: 23.575
Low: 8.3 Change(%): 162.4
|
|
Average Vol(K):
|
3-Month: 3428
10-Days 4413
|
|
|
|
|
|
★
Strong Sell
★★
Sell ★★★
Neutral
★★★★
Buy
★★★★★
Strong Buy
|
|
|
Price, moving averages and
Bollinger Bands
|
|
Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.IRMD has closed below upper band by 26.9%. Bollinger Bands are 131.1% wider than normal. The large width of the bands suggest high volatility as compared to IRMD's normal range. The bands have been in this wide range for 10 bars. This is a sign that the current trend might continue.
|
|
|
Headline News
|
|
2018-04-30T15:37:10-04:00
IRADIMED's (IRMD) CEO Roger Susi on Q1 2018 Results - Earnings Call Transcript
2018-04-30T12:49:42-04:00
Midday Gainers / Losers (04/30/2018)
2018-04-30T08:03:18-04:00
iRadimed Q1 revenues up 37%; raises fiscal guidance
2018-04-30T07:03:25-04:00
iRadimed beats by $0.04, beats on revenue
2018-02-06T17:20:05-05:00
IRADIMED's (IRMD) CEO Roger Susi on Q4 2017 Results - Earnings Call Transcript
2018-01-22T08:23:11-05:00
IRADIMED announces Q1 and FY 2018 financial guidance
2017-11-28T07:43:47-05:00
Your Daily Pharma Scoop: Synergy In 2018, Repatha Action Date, Alkermes Signs Deal
2017-10-30T15:15:42-04:00
IRADIMED's (IRMD) CEO Roger Susi on Q3 2017 Results - Earnings Call Transcript
|
|
|
Financial Analysis
|
|
Growth
|
|
|
Growth measures the growth of both a company's revenue
and net income. it tells investors how fast a company is growing.
|
|
Profitability
|
|
|
Profitability measures a company’s ability to
generate earnings as compared to its expenses
and other relevant costs.
|
|
Solvency
|
|
|
Solvency measures a company's ability to meet its long-term debts.
Acceptable solvency ratios will vary from industry to industry.
|
|
Efficiency
|
|
|
Efficiency measures the strength of a company's return on invested capital.
It can identify business that are better managed or not.
|
|
Click here to get more fundamental analysis.
|
|
